You need JavaScript to view this

THE MANAGEMENT OF THYROID CARCINOMA--THE ROLE OF RADIO-IODINE (I-131)

Abstract

Experience from the management of 156 patients with proven thyroid cancer, followed from 1 to 11 years, is reported. Although no sweeping conclusions can be drawn, it appears that radioiodine continues to have a place in the overall management of most cases of this malignant disease. (auth)
Publication Date:
Jun 15, 1963
Product Type:
Conference
Report Number:
CONF-164-10
Reference Number:
NSA-18-001480
Resource Relation:
Conference: Society of Nuclear Medicine 10th Annual Meeting, Montreal, Quebec (Canada), 26-29 Jun 1963
Subject:
BIOLOGY AND MEDICINE; CANADA; CANCER; CONFERENCE; EFFICIENCY; IODINE ISOTOPES; MAN; RADIOTHERAPY; THYROID
Sponsoring Organizations:
Sponsor not identified
OSTI ID:
4877719
Research Organizations:
Univ. of Maryland, MD (United States). School of Medicine; University Hospital, Baltimore, MD (United States)
Country of Origin:
United States
Language:
English
Submitting Site:
DTIE
Size:
Pages: 8
Announcement Date:
Dec 31, 1964

Citation Formats

Workman, James B. THE MANAGEMENT OF THYROID CARCINOMA--THE ROLE OF RADIO-IODINE (I-131). United States: N. p., 1963. Web.
Workman, James B. THE MANAGEMENT OF THYROID CARCINOMA--THE ROLE OF RADIO-IODINE (I-131). United States.
Workman, James B. 1963. "THE MANAGEMENT OF THYROID CARCINOMA--THE ROLE OF RADIO-IODINE (I-131)." United States.
@misc{etde_4877719,
title = {THE MANAGEMENT OF THYROID CARCINOMA--THE ROLE OF RADIO-IODINE (I-131)}
author = {Workman, James B.}
abstractNote = {Experience from the management of 156 patients with proven thyroid cancer, followed from 1 to 11 years, is reported. Although no sweeping conclusions can be drawn, it appears that radioiodine continues to have a place in the overall management of most cases of this malignant disease. (auth)}
place = {United States}
year = {1963}
month = {Jun}
}